Robert P. Jordheim, Executive Vice President/CFO at RTI Biologics, Inc. (RTIX), bought 5,000 shares at $2.15 ($11K) on 2010-09-09, disclosed to the SEC on 2010-09-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.